alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> UT
<CIK> 0000728391
<NAME> IPALCO ENTERPRISES, INC.
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<BOOK-VALUE>                                  PER-BOOK
<TOTAL-NET-UTILITY-PLANT>                    1,731,350
<OTHER-PROPERTY-AND-INVEST>                     83,840
<TOTAL-CURRENT-ASSETS>                         157,132
<TOTAL-DEFERRED-CHARGES>                       131,115
<OTHER-ASSETS>                                       0
<TOTAL-ASSETS>                               2,103,437
<COMMON>                                       441,150
<CAPITAL-SURPLUS-PAID-IN>                            0
<RETAINED-EARNINGS>                            651,475
<TOTAL-COMMON-STOCKHOLDERS-EQ>                 532,055
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                     59,135
<LONG-TERM-DEBT-NET>                           871,403
<SHORT-TERM-NOTES>                               6,623
<LONG-TERM-NOTES-PAYABLE>                            0
<COMMERCIAL-PAPER-OBLIGATIONS>                       0
<LONG-TERM-DEBT-CURRENT-PORT>                   85,025
<PREFERRED-STOCK-CURRENT>                            0
<CAPITAL-LEASE-OBLIGATIONS>                          0
<LEASES-CURRENT>                                     0
<OTHER-ITEMS-CAPITAL-AND-LIAB>                 549,196
<TOT-CAPITALIZATION-AND-LIAB>                2,103,437
<GROSS-OPERATING-REVENUE>                      403,841
<INCOME-TAX-EXPENSE>                            43,500
<OTHER-OPERATING-EXPENSES>                     267,656
<TOTAL-OPERATING-EXPENSES>                     311,156
<OPERATING-INCOME-LOSS>                         92,685
<OTHER-INCOME-NET>                               4,654
<INCOME-BEFORE-INTEREST-EXPEN>                  97,339
<TOTAL-INTEREST-EXPENSE>                        33,090
<NET-INCOME>                                    64,249
<PREFERRED-STOCK-DIVIDENDS>                      1,607
<EARNINGS-AVAILABLE-FOR-COMM>                   64,249
<COMMON-STOCK-DIVIDENDS>                        25,203
<TOTAL-INTEREST-ON-BONDS>                            0
<CASH-FLOW-OPERATIONS>                         130,096
<EPS-BASIC>                                        .74
<EPS-DILUTED>                                      .74


</TABLE>
115 STAT. 898 PUBLIC LAW 107–92—DEC. 21, 2001

LEGISLATIVE HISTORY—H.R. 1761:

CONGRESSIONAL RECORD, Vol. 147 (2001):

Sept. 10, considered and passed House.

Dec. 6, considered and passed Senate.

Æ

Public Law 107–92

107th Congress

An Act

To designate the facility of the United States Postal Service located at 8588 Richmond

Highway in Alexandria, Virginia, as the ‘‘Herb Harris Post Office Building’’.

Be it enacted by the Senate and House of Representatives of

the United States of America in Congress assembled,

SECTION 1. DESIGNATION.

The facility of the United States Postal Service located at

8588 Richmond Highway in Alexandria, Virginia, shall be known

and designated as the ‘‘Herb Harris Post Office Building’’.

SEC. 2. REFERENCES.

Any reference in a law, map, regulation, document, paper,

or other record of the United States to the facility referred to

in section 1 shall be deemed to be a reference to the ‘‘Herb Harris

Post Office Building’’.

Approved December 21, 2001.

Dec. 21, 2001

[H.R. 1761]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institute for Occupational Safety and Health

# AGENCY:

National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS).

# ACTION:

Notice.

# SUMMARY:

HHS gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees for the Weldon Spring Plant, Weldon Spring, Missouri, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows:

*Facility:*                         Weldon Spring Plant.                    

*Location:*                         Weldon Spring, Missouri.                    

*Job Titles and/or Job Duties:*                         All employees of DOE, DOE contractors, or subcontractors who worked in any area.                    

*Period of Employment:*                         January 1, 1957 through December 31, 1966.                    

# FOR FURTHER INFORMATION CONTACT:

                        Larry Elliott, Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C-46, Cincinnati, OH 45226, Telephone 513-533-6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to                         *OCAS@CDC.GOV*.                    

 John Howard,

Director, National Institute for Occupational Safety and Health.

[FR Doc. E9-22745 Filed 9-21-09; 8:45 am]

BILLING CODE 4163-19-P
HomeArms Control and Nonproliferation...Arms Control and Nonproliferation

# Arms Control and Nonproliferation

232 items

        -    TIAS  		Latvia (03-505) – Agreement Concerning Cooperation in the Area of Prevention of the Proliferation of Weapons of Mass Destruction	  May 5, 2003 
        -    TIAS  		Lithuania (03-424) – Agreement Concerning Cooperation in the Area of Prevention of Proliferation of Weapons of Mass Destruction and the Promotion of Defense and Military Relations	  April 24, 2003 
        -    TIAS  		Uzbekistan (02-312) – Agreement Concerning Cooperation in the Area of Proliferation on Nuclear Materials and Technology	  March 12, 2002 
        -    TIAS  		Ukraine (01-920) – Agreement on the Establishment of Communication between Centers	  September 20, 2001 
        -    TIAS  		Botswana (00-216) – Agreement Concerning the Operation of a Seismic Monitoring Station in Botswana	  February 16, 2000 
        -    TIAS  		Paraguay (99-913) – Memorandum of Understanding Concerning the Operation of a Seismic Monitoring Station in Paraguay	  September 13, 1999 
        -    TIAS  		Kazakhstan (12901) – Agreement Concerning the Establishment and Operation of Nuclear Test Seismic Monitoring Stations in Kazakhstan	  November 18, 1997 
        -    TIAS  		Multilateral (97-525) – Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on Their Destruction	  May 25, 1997 
        -    Depositary – Treaty Affairs  		Biological Weapons Convention	   
        -    Depositary – Treaty Affairs  		3. Treaty on the Prohibition of the Emplacement of Nuclear Weapons and Other Weapons of Mass Destruction on the Seabed and the Ocean Floor and in the Subsoil Thereof, done at London, Moscow, and Washington February 11, 1971	   

previous page1…21222324next page

Back to Top
Editorial Note on Part 84
Editorial Note: Nomenclature changes to part 84 appear at 69 FR 18803, Apr. 9, 2004.

§ 84.191 Chemical cartridge respirators; required components. ( a ) Each chemical cartridge respirator described in § 84.190 shall, where its design requires, contain the following component parts: ( 1 ) Facepiece, mouthpiece, and noseclip, hood, or helmet;
( 2 ) Cartridge;
( 3 ) Cartridge with filter;
( 4 ) Harness;
( 5 ) Breathing tube; and
( 6 ) Attached blower.
( b ) The components of each chemical cartridge respirator shall meet the minimum construction requirements set forth in subpart G of this part.
Document

CONFIDENTIAL & PROPRIETARY                                                                                                               Exhibit 10.16

ADDENDUM NO. 2 TO MANUFACTURING, QUALITY AND SUPPLY AGREEMENT


    THIS ADDENDUM NO. 2 TO MANUFACTURING, QUALITY AND SUPPLY AGREEMENT (“Addendum No. 2”), effective as of July 1, 2020 (“Addendum Effective Date”) is by and between SI-BONE, Inc., a Delaware corporation having a principal place of business at 471 El Camino Real, Suite 101, Santa Clara, California 95050 (“SI-BONE”) and rms Company (“Customer”), a Minnesota corporation having a principal place of business at 8600 Evergreen Blvd., Coon Rapids, MN 55433, and amends that certain Manufacturing, Quality and Supply Agreement between the parties with an effective date of January 31, 2017 as amended by that certain addendum dated July 7, 2017 (the “Existing Agreement” and together with this Addendum No. 1, the “Agreement”).  Capitalized terms used and not defined herein shall have the meaning given them in the Existing Agreement.


The parties agree as follows:


1.Schedule A to Addendum No. 1.  The parties hereby agree that Schedule A to Addendum No. 1 is amended and restated in its entirety with the Schedule A to Addendum No. 2 attached hereto. 


2.Pricing Addendum.  The parties hereby agree that the Exhibit A (Pricing Addendum) of the Agreement is amended and restated in its entirety with the Exhibit A (Pricing Addendum) attached hereto.


3.Miscellaneous.


a.Ratification.  The parties take this opportunity to ratify the Existing Agreement and confirm all of their respective obligations set forth therein, including the representations and warranties made to one another.  


b.Severability.  If any provision of the Agreement will be declared invalid, illegal or unenforceable, such provision will be severed and all remaining provisions will continue in full force and effect.


c.Entire Agreement.  The Agreement, including this Addendum No. 2, is the full, complete, and exclusive agreement between the parties and supersedes and cancels any and all previous or contemporaneous agreements of whatever nature, whether written or oral, between Customer and SI-BONE and SI-BONE’s subsidiaries and affiliates with respect to its subject matter.  The Agreement may only be modified or amended in a writing signed by both parties.  Subject headings are for convenience of reference only and will in no way affect interpretation of the Agreement.


d.Counterparts.  This Addendum No. 2 may be executed in separate counterparts, and by facsimile, each of which will be deemed an original, and when executed separately or together, will constitute a single original instrument, effective in the same manner as if the parties had executed one and the same instrument.




IN WITNESS WHEREOF, the parties have executed this Addendum No. 2 as of the date set forth beneath such person’s name.


						
	SI-BONE, Inc.	rms Company
	By: /s/ Michael Blanchard	By: /s/ Richard S. Riddle
	Name: Michael Blanchard
	Name: Richard S. Riddle

	Title: VP, Operations	Title: Director of Sales
	Date Signed: 7/7/2020	Date Signed: 6-July-2020
<PAGE>
 
                                  EXHIBIT 15
                                  ----------

               LETTER RE UNAUDITED INTERIM FINANCIAL INFORMATION
               -------------------------------------------------



                                      109
<PAGE>
 
                                                                      Exhibit 15


Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549



We are aware that our report dated April 9, 1997 on our review of interim
financial information of Life Technologies, Inc. (the Company) for the three-
month periods ended March 31, 1997 and 1996, included in this Form 10-Q is
incorporated by reference in the Company's registration statements on Form S-8,
Registration No. 333-03773, Registration No. 33-59741, Registration No. 33-21807
and Registration No. 33-956, and the Company's registration statement on Form S-
3, Registration No. 33-29536.  Pursuant to Rule 436(c) under the Securities Act
of 1933, this report should not be considered a part of the registration
statements prepared or certified by us within the meaning of Section 7 and 11 of
that Act.


                                    /s/ Coopers & Lybrand L.L.P.
                                    COOPERS & LYBRAND L.L.P.



Rockville, Maryland
April 9, 1997

                                      110
****

This chart presents 1997 West Virginia exports to the Newly IndependentStates of the former Soviet Union.  Data used to create the chart werecollected by the Bureau of the Census, U.S. Department of Commerce,with further analysis by the University of Massachusetts,Massachusetts Institute for Social and Economic Research (MISER). Formore information call BISNIS at (202) 482-4655 or visit the MISER websiteat www.umass.edu/miser.
'96 export data for West Virginia
'95 export data for West Virginia
Return to USA Export Map
Return to BISNIS Home Page
###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.

#### § 11.506 Restrictions on right to practice.

A practitioner shall not participate in offering or making:

(a) A partnership, shareholders, operating, employment, or other similar type of agreement that restricts the right of a practitioner to practice after termination of the relationship, except an agreement concerning benefits upon retirement; or

(b) An agreement in which a restriction on the practitioner's right to practice is part of the settlement of a client controversy.
<PAGE>

                                                               Exhibit 10.10(14)

               SECOND MODIFICATION TO LOAN AND SECURITY AGREEMENT

         This SECOND Modification to Loan and Security Agreement (this
"Modification") is entered into by and between FOTOBALL USA, INC. ("Borrower")
and COMERICA BANK successor by merger to Comerica Bank - California, a
California banking corporation ("Bank") as of this 30TH DAY OF SEPTEMBER, 2003,
at San Jose, California.

                                    RECITALS

         This Modification is entered into upon the basis of the following facts
and understandings of the parties, which facts and understandings are
acknowledged by the parties to be true and accurate:

         Bank and Borrower previously entered into a Loan and Security Agreement
(Accounts and Inventory) dated JUNE 24, 2002, which was subsequently amended
pursuant to that certain modification agreement dated APRIL 16, 2003. The Loan
and Security Agreement and each modification shall collectively be referred to
herein as the "Agreement".

         NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties agree as set forth
below.

                                    AGREEMENT

         1. Incorporation by Reference. The Recitals and the documents referred
to therein are incorporated herein by this reference. Except as otherwise noted,
the terms not defined herein shall have the meaning set forth in the Agreement.

         2. Modification to the Agreement. Subject to the satisfaction of the
conditions precedent as set forth in Section 3 hereof, the Agreement is hereby
modified as set forth below.

               A. "Section 6.16(d) of the Agreement hereby is deleted in its
          entirety and replaced with the following:

                    "(d) Intentionally Omitted."

               B. "Section 6.16(e) of the Agreement hereby is deleted in its
          entirety and replaced with the following:

                    "(e) Intentionally Omitted."

         3. Legal Effect. The effectiveness of this Modification is conditioned
upon receipt by Bank of this Modification, and any other documents which Bank
may require to carry out the terms hereof. Except as specifically set forth in
this Modification, all of the terms and conditions of the Agreement remain in
full force and effect.

         4. Integration. This is an integrated Modification and supersedes all
prior negotiations and agreements regarding the subject matter hereof. All
amendments hereto must be in writing and signed by the parties.

         IN WITNESS WHEREOF, the parties have agreed as of the date first set
forth above.


FOTOBALL USA, Inc.                        COMERICA BANK

By: /s/ Thomas R. Hillebrandt             By:/s/ Stephen Cusato
    -------------------------------          -----------------------------------
    Thomas R. Hillebrandt                 Stephen Cusato
Title: Sr. Vice President & CFO           Senior Vice President-Western Division
       ----------------------------
```

[107th Congress Public Law 98]
[From the U.S. Government Printing Office]

<DOC>
[DOCID: f:publ098.107]

Public Law 107-98
107th Congress

                            Joint Resolution

 
 Appointing the day for the convening of the second session of the One 
  Hundred Seventh Congress. <<NOTE: Dec. 21, 2001 -  [H.J. Res. 80]>> 

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled,

SECTION 1. DAY FOR CONVENING OF SECOND REGULAR SESSION OF ONE HUNDRED 
            SEVENTH CONGRESS.

    The second regular session of the One Hundred Seventh Congress shall 
begin at noon on Wednesday, January 23, 2002.

SEC. 2. AUTHORITY FOR CALLING SPECIAL SESSION BEFORE CONVENING OF SECOND 
            REGULAR SESSION.

    If the Speaker of the House of Representatives and the Majority 
Leader of the Senate, acting jointly after consultation with the 
Minority Leader of the House of Representatives and the Minority Leader 
of the Senate, determine that it is in the public interest for Congress 
to assemble before the convening of the second regular session of the 
One Hundred Seventh Congress as provided in section 1--
            (1) the Speaker and Majority Leader shall notify the Members 
        of the House and Senate, respectively, of such determination and 
        of the place and time for Congress to so assemble; and
            (2) Congress shall assemble in accordance with such 
        notification.

    Approved December 21, 2001.

LEGISLATIVE HISTORY--H.J. Res. 80:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 147 (2001):
            Dec. 20, considered and passed House and Senate.

                                  <all>
```
- GP COVID-19 Information
- COVID-19 Fund

HomeOffice of Global Partnerships...Office of Global Partnerships: Coronavirus Disease 2019 (COVID-19) Information and Resources

# 									Office of Global Partnerships: Coronavirus Disease 2019 (COVID-19) Information and Resources							

Office of Global Partnerships

History has taught us that responding to infectious disease outbreaks such as HIV, Ebola, malaria, and Zika require a whole-of-society response. The U.S. Department of State recognizes that public health crises have multi-faceted impacts on affected countries and require a multi-sectoral response. In addition to our bilateral and multilateral partnerships with other governments and international organizations, we seek to coordinate and collaborate with the private sector, non-profits, foundations, corporations, and academic and research institutions to address concerns and fill gaps in our response to effectively fight COVID-19 internationally.

We need to communicate clearly, with each other and with the public, in the face of this global pandemic. We want to encourage the innovation, creativity, and problem-solving capabilities that the private sector have to offer. We need to redouble our efforts and work together to implement a whole-of-society response to effectively resolve a crisis that has affected the whole world.

We will be hosting virtual convenings to discuss this initiative in more detail in the coming months, with the first event taking place in January 2021. The virtual convenings will address the following questions:
        - What activities is your organization undertaking with respect to the pandemic?
        - What countries or regions are you working in?
        - What resources or contributions you have you committed thus far?
        - How can the Department best support your work?

Please contact us for more details: Partnerships@state.gov. Please limit your responses to no more than two pages. Questions can also be sent to the same address.

For all COVID-19 related resources, please visit the Department of State’s Coronavirus page at  https://www.state.gov/coronavirus/ and The Centers for Disease Control and Prevention (CDC) page at https://www.cdc.gov/coronavirus/.

Tags

COVID-19Public-Private PartnershipsOffice of Global Partnerships

Back to Top